How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review

被引：0
|
作者：
Mikyung Kelly Seo
John Cairns
机构：
[1] London School of Hygiene and Tropical Medicine,Department of Health Services Research and Policy, Faculty of Public Health and Policy
[2] University of Bergen,Centre for Cancer Biomarkers (CCBIO)
[3] Department of Surgery and Cancer,undefined
[4] Faculty of Medicine,undefined
[5] Imperial College London,undefined
[6] Department of Public Health and Primary Care,undefined
[7] School of Clinical Medicine,undefined
[8] University of Cambridge,undefined
来源：
BMC Cancer | / 21卷
关键词：
Biomarker; Companion biomarker; Companion diagnostic; Precision medicine; Targeted therapy; Oncology; Cancer; Economic evaluation; Health economics; Cost-effectiveness; Systematic review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Disease modifying therapies in multiple sclerosis: cost-effectiveness systematic review
    Eduardo Navarro, Cristian
    Ordonez-Callamand, Eliana
    Pablo Alzate, Juan
    [J]. FARMACIA HOSPITALARIA, 2020, 44 (02) : 68 - 76
  • [22] SYSTEMATIC REVIEW OF COST-EFFECTIVENESS ANALYSES OF ULTRA-ORPHAN THERAPIES
    Aggarwal, S.
    Topaloglu, H.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A247 - A247
  • [23] How Are We Measuring Cost-Effectiveness in Total Joint Arthroplasty Studies? Systematic Review of the Literature
    Lan, Roy H.
    Yu, Jessica
    Samuel, Linsen T.
    Pappas, Matthew A.
    Brooks, Peter J.
    Kamath, Atul F.
    [J]. JOURNAL OF ARTHROPLASTY, 2020, 35 (11): : 3364 - 3374
  • [24] Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer
    Seo, Mikyung Kelly
    Cairns, John
    [J]. PLOS ONE, 2018, 13 (09):
  • [25] Systematic Review and Quality Assessment of Cost-Effectiveness Analysis of Pharmaceutical Therapies for Advanced Colorectal Cancer
    Leung, Henry W. C.
    Chan, Agnes L. F.
    Leung, Matthew S. H.
    Lu, Chin-Li
    [J]. ANNALS OF PHARMACOTHERAPY, 2013, 47 (04) : 506 - 518
  • [26] THE COST-EFFECTIVENESS OF COMPANION DIAGNOSTICS IN CANCER THERAPY
    Mathurin, K.
    Beauchemin, C.
    Lachaine, J.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A142 - A142
  • [27] Evaluating the Quality of Cost-Effectiveness Literature in Breast Surgery: What Do We Do Well and How Can We Do Better? A Systematic Review
    Char, Sydney N.
    Bloom, Joshua A.
    DeMarco, Danielle
    Chatterjee, Abhishek
    [J]. AMERICAN SURGEON, 2022, 88 (11) : 2660 - 2669
  • [28] A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer
    Diaby, Vakaramoko
    Tawk, Rima
    Sanogo, Vassiki
    Xiao, Hong
    Montero, Alberto J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2015, 151 (01) : 27 - 40
  • [29] A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer
    Vakaramoko Diaby
    Rima Tawk
    Vassiki Sanogo
    Hong Xiao
    Alberto J. Montero
    [J]. Breast Cancer Research and Treatment, 2015, 151 : 27 - 40
  • [30] A Systematic Review on Cost-effectiveness Studies Evaluating Ovarian Cancer Early Detection and Prevention Strategies
    Sroczynski, Gaby
    Gogollari, Artemisa
    Kuehne, Felicitas
    Hallsson, Lara R.
    Widschwendter, Martin
    Pashayan, Nora
    Siebert, Uwe
    [J]. CANCER PREVENTION RESEARCH, 2020, 13 (05) : 429 - 442
12345